Arrowhead Research said that it has appointed City of Hope researcher John Rossi to the scientific advisory board of subsidiary Calando Pharmaceuticals.
Rossi is one of Calando's co-founders. He also co-founded RNAi firm Dicerna Pharmaceuticals, and is a member of the SABs of Benitec and Kylin Therapeutics.